Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
n-3 fatty acids in patients with multiple cardiovascular risk factors.
Risk and Prevention Study Collaborative Group; Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R. Risk and Prevention Study Collaborative Group, et al. Among authors: silletta mg. N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. N Engl J Med. 2013. PMID: 23656645 Free article. Clinical Trial.
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.
n-3 fatty acids in patients with cardiac risk factors.
Roncaglioni MC, Tombesi M, Silletta MG. Roncaglioni MC, et al. Among authors: silletta mg. N Engl J Med. 2013 Aug 22;369(8):781-2. doi: 10.1056/NEJMc1308780. N Engl J Med. 2013. PMID: 23964942 No abstract available.
Improving cardiovascular prevention in general practice: Results of a comprehensive personalized strategy in subjects at high risk.
Avanzini F, Marzona I, Baviera M, Barlera S, Milani V, Caimi V, Longoni P, Tombesi M, Silletta MG, Tognoni G, Roncaglioni MC; Risk and Prevention Study Collaborative Group. Avanzini F, et al. Among authors: silletta mg. Eur J Prev Cardiol. 2016 Jun;23(9):947-55. doi: 10.1177/2047487315613664. Epub 2015 Nov 2. Eur J Prev Cardiol. 2016. PMID: 26525065 Clinical Trial.
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G. Marchioli R, et al. Among authors: silletta mg. J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7. doi: 10.2459/01.JCM.0000289271.80180.b6. J Cardiovasc Med (Hagerstown). 2007. PMID: 17876196
Meta-analysis of effect of statin treatment on risk of sudden death.
Levantesi G, Scarano M, Marfisi R, Borrelli G, Rutjes AW, Silletta MG, Tognoni G, Marchioli R. Levantesi G, et al. Among authors: silletta mg. Am J Cardiol. 2007 Dec 1;100(11):1644-50. doi: 10.1016/j.amjcard.2007.07.015. Epub 2007 Oct 24. Am J Cardiol. 2007. PMID: 18036362
Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.
Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R; GISSI-Prevenzione Investigators. Silletta MG, et al. Circulation. 2007 Dec 18;116(25):2944-51. doi: 10.1161/CIRCULATIONAHA.107.712976. Epub 2007 Dec 3. Circulation. 2007. PMID: 18056527
36 results